New vaccine technologies to combat outbreak situations

S Rauch, E Jasny, KE Schmidt, B Petsch - Frontiers in immunology, 2018 - frontiersin.org
Ever since the development of the first vaccine more than 200 years ago, vaccinations have
greatly decreased the burden of infectious diseases worldwide, famously leading to the …

Adenoviral vector-based vaccine platform for COVID-19: Current status

VP Chavda, R Bezbaruah, D Valu, B Patel, A Kumar… - Vaccines, 2023 - mdpi.com
The coronavirus disease (COVID-19) breakout had an unimaginable worldwide effect in the
21st century, claiming millions of lives and putting a huge burden on the global economy …

Nanocarrier vaccines for SARS-CoV-2

J Machhi, F Shahjin, S Das, M Patel… - Advanced Drug Delivery …, 2021 - Elsevier
The SARS-CoV-2 global pandemic has seen rapid spread, disease morbidities and death
associated with substantive social, economic and societal impacts. Treatments rely on re …

Tunable and reversible drug control of protein production via a self-excising degron

HK Chung, CL Jacobs, Y Huo, J Yang… - Nature chemical …, 2015 - nature.com
An effective method for direct chemical control over the production of specific proteins would
be widely useful. We describe small molecule–assisted shutoff (SMASh), a technique in …

An overview of nanocarrier-based adjuvants for vaccine delivery

KC Petkar, SM Patil, SS Chavhan, K Kaneko… - Pharmaceutics, 2021 - mdpi.com
The development of vaccines is one of the most significant medical accomplishments which
has helped to eradicate a large number of diseases. It has undergone an evolutionary …

Novel viral vectors in infectious diseases

IR Humphreys, S Sebastian - Immunology, 2018 - Wiley Online Library
Since the development of vaccinia virus as a vaccine vector in 1984, the utility of numerous
viruses in vaccination strategies has been explored. In recent years, key improvements to …

Replicating and non-replicating viral vectors for vaccine development

M Robert-Guroff - Current opinion in biotechnology, 2007 - Elsevier
Viral vectors provide a convenient means to deliver vaccine antigens to select target cells or
tissues. A broad spectrum of replicating and non-replicating vectors is available. An …

Review of dengue virus and the development of a vaccine

S Murrell, SC Wu, M Butler - Biotechnology advances, 2011 - Elsevier
Dengue viral infection has become an increasing global health concern with over two-fifths
of the world's population at risk of infection. It is the most rapidly spreading vector borne …

Multivalent and multipathogen viral vector vaccines

KB Lauer, R Borrow, TJ Blanchard - Clinical and Vaccine …, 2017 - Am Soc Microbiol
The presentation and delivery of antigens are crucial for inducing immunity and, desirably,
lifelong protection. Recombinant viral vectors—proven safe and successful in veterinary …

A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus

S Brandler, C Ruffié, C Combredet, JB Brault… - Vaccine, 2013 - Elsevier
Chikungunya virus (CHIKV), a mosquito-transmitted alphavirus, recently reemerged in the
Indian Ocean, India and Southeast Asia, causing millions of cases of severe polyarthralgia …